08/06/2011 (Natural Products Insider) - Tocotrienol science and market potential will be the focus of the Malaysian Palm Oil Board’s (MPOB) second International Conference on “Tocotrienols and Chronic Diseases" from July 13  to 14 at Wynn Resort, Las Vegas. Product manufacturers who attend can hear experts from around the world who have spent years studying palm tocotrienol/tocopherol complex.

Carotech Inc., a GMP (good manufacturing practice)-certified tocotrienol producer,  will present science on its Tocomin SupraBio® patented and bioenhanced full spectrum palm tocotrienol complex that has shown promising results in supporting healthy brain in stroke-related injuries, cholesterol lowering, radiation protection, treatment for non-alcoholic fatty liver disease, anti-inflammation, chemoprevention, cancer cells apoptosis, acceleration of wound healing and scar reduction post surgery.

Carotech worked with the MPOB before by helping to assistance in organizing its palm fruit bioactives conference in conjunction with Hi Europe/Ni in Madrid, Spain on Nov. 17, 2010, following the success of the SupplySide West conference in Las Vegas.

The recent FDA’s final notification of no objection for GRAS status of palm tocotrienol complex (Tocomin®, Carotech Inc.) allows it to be used in food and beverage products.

“Carotech’s Tocomin® and Tocomin SupraBio are used in most of the tocotrienol studies," said WH Leong, vice president, Carotech Inc. “Being the largest and the only GMP-certified tocotrienol producer in the world, Carotech will continue to emphasize on solid science and clinical trials to promotes is Tocomin® / Tocomin SupraBio® natural full spectrum f palm tocotrienol complex."

Tocomin SupraBio® is a patented (US Patent No. 6,596,306) self emulsifying palm tocotrienol complex that is designed for optimal tocotrienols oral absorption.